Cellular phenotypic transitions in diabetic nephropathy: an update
Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the most common cause of end stage renal disease (ESRD). Renal fibrosis is the final pathological change in DN. It is widely believed that cellular phenotypic switching is the cause of renal fibrosis in diabetic...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
02 November 2022
|
| In: |
Frontiers in pharmacology
Year: 2022, Jahrgang: 13, Pages: 1-15 |
| ISSN: | 1663-9812 |
| DOI: | 10.3389/fphar.2022.1038073 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fphar.2022.1038073 Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fphar.2022.1038073 
|
| Verfasserangaben: | Yiling Cao, Ji-Hong Lin, Hans-Peter Hammes and Chun Zhang |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 185225971X | ||
| 003 | DE-627 | ||
| 005 | 20240307090517.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230710s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fphar.2022.1038073 |2 doi | |
| 035 | |a (DE-627)185225971X | ||
| 035 | |a (DE-599)KXP185225971X | ||
| 035 | |a (OCoLC)1425217362 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Cao, Yi-Ling |e VerfasserIn |0 (DE-588)1259766179 |0 (DE-627)1806869381 |4 aut | |
| 245 | 1 | 0 | |a Cellular phenotypic transitions in diabetic nephropathy |b an update |c Yiling Cao, Ji-Hong Lin, Hans-Peter Hammes and Chun Zhang |
| 264 | 1 | |c 02 November 2022 | |
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.07.2023 | ||
| 520 | |a Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the most common cause of end stage renal disease (ESRD). Renal fibrosis is the final pathological change in DN. It is widely believed that cellular phenotypic switching is the cause of renal fibrosis in diabetic nephropathy. Several types of kidney cells undergo activation and differentiation and become reprogrammed to express markers of mesenchymal cells or podocyte-like cells. However, the development of targeted therapy for DN has not yet been identified. Here, we discussed the pathophysiologic changes of DN and delineated the possible origins that contribute to myofibroblasts and podocytes through phenotypic transitions. We also highlight the molecular signaling pathways involved in the phenotypic transition, which would provide valuable information for the activation of phenotypic switching and designing effective therapies for DN. | ||
| 700 | 1 | |a Lin, Ji-Hong |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hammes, Hans-Peter |d 1955- |e VerfasserIn |0 (DE-588)102028353X |0 (DE-627)691169772 |0 (DE-576)360007252 |4 aut | |
| 700 | 1 | |a Zhang, Chun |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in pharmacology |d Lausanne : Frontiers Media, 2010 |g 13(2022) vom: Nov., Artikel-ID 1038073, Seite 1-15 |h Online-Ressource |w (DE-627)642889392 |w (DE-600)2587355-6 |w (DE-576)335527108 |x 1663-9812 |7 nnas |a Cellular phenotypic transitions in diabetic nephropathy an update |
| 773 | 1 | 8 | |g volume:13 |g year:2022 |g month:11 |g elocationid:1038073 |g pages:1-15 |g extent:15 |a Cellular phenotypic transitions in diabetic nephropathy an update |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fphar.2022.1038073 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fphar.2022.1038073 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230710 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 102028353X |a Hammes, Hans-Peter |m 102028353X:Hammes, Hans-Peter |d 60000 |d 61400 |e 60000PH102028353X |e 61400PH102028353X |k 0/60000/ |k 1/60000/61400/ |p 3 | ||
| 999 | |a KXP-PPN185225971X |e 435174989X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"15 S."}],"language":["eng"],"recId":"185225971X","id":{"eki":["185225971X"],"doi":["10.3389/fphar.2022.1038073"]},"name":{"displayForm":["Yiling Cao, Ji-Hong Lin, Hans-Peter Hammes and Chun Zhang"]},"origin":[{"dateIssuedDisp":"02 November 2022","dateIssuedKey":"2022"}],"title":[{"title":"Cellular phenotypic transitions in diabetic nephropathy","title_sort":"Cellular phenotypic transitions in diabetic nephropathy","subtitle":"an update"}],"person":[{"family":"Cao","display":"Cao, Yi-Ling","role":"aut","given":"Yi-Ling"},{"given":"Ji-Hong","family":"Lin","display":"Lin, Ji-Hong","role":"aut"},{"role":"aut","display":"Hammes, Hans-Peter","family":"Hammes","given":"Hans-Peter"},{"given":"Chun","role":"aut","display":"Zhang, Chun","family":"Zhang"}],"relHost":[{"note":["Gesehen am 08.09.20"],"title":[{"title":"Frontiers in pharmacology","title_sort":"Frontiers in pharmacology"}],"origin":[{"publisherPlace":"Lausanne","dateIssuedDisp":"2010-","dateIssuedKey":"2010","publisher":"Frontiers Media"}],"pubHistory":["2010 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1663-9812"],"zdb":["2587355-6"],"eki":["642889392"]},"recId":"642889392","part":{"pages":"1-15","volume":"13","text":"13(2022) vom: Nov., Artikel-ID 1038073, Seite 1-15","year":"2022","extent":"15"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Cellular phenotypic transitions in diabetic nephropathy an updateFrontiers in pharmacology"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 10.07.2023"]} | ||
| SRT | |a CAOYILINGLCELLULARPH0220 | ||